The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2019

Filed:

Jan. 18, 2018
Applicant:

Akeso Biomedical, Inc., Waltham, MA (US);

Inventors:

Dlawer Ala'Aldeen, Watford, GB;

Jafar Mahdavi, Nottingham, GB;

Panos Soultanas, Nottingham, GB;

Assignee:

Akeso Biomedical, Inc., Waltham, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01K 43/00 (2006.01); A61Q 11/00 (2006.01); A61K 31/295 (2006.01); A61Q 17/00 (2006.01); A23K 20/20 (2016.01); C07F 15/02 (2006.01); A23L 2/52 (2006.01); A61K 45/06 (2006.01); A01K 67/00 (2006.01); A22C 21/00 (2006.01); A22C 18/00 (2006.01); A01K 14/00 (2006.01); A01K 45/00 (2006.01); A01N 43/40 (2006.01); A01N 59/16 (2006.01); C09D 5/14 (2006.01); A61K 31/00 (2006.01); A23K 50/75 (2016.01); A23L 33/165 (2016.01); A01N 37/36 (2006.01); A01N 37/38 (2006.01); A01N 37/42 (2006.01); A61K 8/36 (2006.01); A61K 8/365 (2006.01); A61K 8/368 (2006.01); A61K 8/41 (2006.01); A61K 8/19 (2006.01); A61K 31/555 (2006.01); A61K 31/7036 (2006.01);
U.S. Cl.
CPC ...
A01K 43/00 (2013.01); A01K 14/00 (2013.01); A01K 45/005 (2013.01); A01K 67/00 (2013.01); A01N 37/36 (2013.01); A01N 37/38 (2013.01); A01N 37/42 (2013.01); A01N 43/40 (2013.01); A01N 59/16 (2013.01); A22C 18/00 (2013.01); A22C 21/00 (2013.01); A23K 20/20 (2016.05); A23K 20/30 (2016.05); A23K 50/75 (2016.05); A23L 2/52 (2013.01); A23L 33/165 (2016.08); A61K 8/19 (2013.01); A61K 8/361 (2013.01); A61K 8/365 (2013.01); A61K 8/368 (2013.01); A61K 8/41 (2013.01); A61K 31/00 (2013.01); A61K 31/295 (2013.01); A61K 31/555 (2013.01); A61K 31/7036 (2013.01); A61K 45/06 (2013.01); A61Q 11/00 (2013.01); A61Q 17/005 (2013.01); C07F 15/025 (2013.01); C09D 5/14 (2013.01); A23V 2002/00 (2013.01); A61K 2800/58 (2013.01);
Abstract

A method of enhancing the growth of an animal is provided. The method includes causing the animal to ingest or absorb an effective amount of one or more Fe III complex compounds, including but not limited to Fe III complexes comprising ligands bound to the iron center selected from amino acids or α-hydroxy acids, o-hydroxy benzoic acids or pyridine-2-carboxylic acids, such as ferric quinate, ferric tyrosine, ferric DOPA and ferric phenylalanine. Compounds which are structural and/or functional variants, derivatives and/or analogs of the foregoing compounds, as further described herein are also disclosed. Methods for inhibiting, reducing, or preventing biofilm formation or buildup on a surface; the treatment of, inhibition of growth of, and inhibition of colonization by, bacteria, both in biological and non-biological environments; disinfecting surfaces, potentiating the effects of antibiotics and other anti-microbial agents, and increasing the sensitivity of bacteria and other microorganisms, to anti-microbial agents are also provided.


Find Patent Forward Citations

Loading…